CAS: 183721-15-5 - mrs-1220
Fórmula:C21H14ClN5O2
InChI:InChI=1/C21H14ClN5O2/c22-14-8-9-16-15(12-14)20-25-19(17-7-4-10-29-17)26-27(20)21(23-16)24-18(28)11-13-5-2-1-3-6-13/h1-10,12H,11H2,(H,23,24,28)
- Sinónimos:
- N-(9-chloro-2-furan-2-yl[1,2,4]triazolo[1,5-c]quinazolin-5-yl)-2-phenylacetamide
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | 9-CHLORO-2-(2-FURANYL)-5-[(PHENYLACETY)AMINO][1,2,4]-TRIAZOLO[1,5-C] QUINAZOLINE REF: IN-DA00AEBMCAS: 183721-15-5 | 96% | A consultar | Mar 26 Nov 24 |
 | MRS 1220 REF: 3D-FM30704CAS: 183721-15-5 | Min. 95% | A consultar | Mar 07 Ene 25 |
 | MRS1220 REF: TM-T23016CAS: 183721-15-5 | 96.59% | A consultar | Mar 14 Ene 25 |
![9-CHLORO-2-(2-FURANYL)-5-[(PHENYLACETY)AMINO][1,2,4]-TRIAZOLO[1,5-C] QUINAZOLINE](https://static.cymitquimica.com/products/IN/thumb/DA00AEBM.jpg)
9-CHLORO-2-(2-FURANYL)-5-[(PHENYLACETY)AMINO][1,2,4]-TRIAZOLO[1,5-C] QUINAZOLINE
CAS:183721-15-5
Fórmula:
C21H14ClN5O2
Pureza:
96%
Forma y color:
Solid
Peso molecular:
403.8212
Ref: IN-DA00AEBM
| 1mg | 133,00 € | ||
| 5mg | 225,00 € | ||
| 10mg | 479,00 € | ||
| 25mg | 533,00 € | ||
| 50mg | A consultar | ||
| 100mg | A consultar | ||
| 500mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 26 de Noviembre de 2024
MRS 1220
CAS:183721-15-5
Antagonist of adenosine receptor A3
Fórmula:
C21H14ClN5O2
Pureza:
Min. 95%
Peso molecular:
403.82 g/mol
Ref: 3D-FM30704
| 1mg | A consultar | ||
| 2mg | A consultar | ||
| 5mg | A consultar | ||
| 250µg | A consultar | ||
| 500µg | A consultar |
Entrega estimada en Estados Unidos, el Martes 7 de Enero de 2025
MRS1220
CAS:183721-15-5
MRS1220, a selective and potent antagonist for the human A3 adenosine receptor (hA3AR) with a …
Fórmula:
C21H14ClN5O2
Pureza:
96.59%
Forma y color:
Solid
Peso molecular:
403.82
Ref: TM-T23016
| 1mg | 49,00 € | ||
| 5mg | 114,00 € | ||
| 10mg | 174,00 € | ||
| 25mg | 297,00 € | ||
| 50mg | 428,00 € | ||
| 100mg | 603,00 € | ||
| 500mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 14 de Enero de 2025
